Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
OtherClinical Investigations (Human)

Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide

Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, Francois Benard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe
Journal of Nuclear Medicine February 2021, jnumed.120.259069; DOI: https://doi.org/10.2967/jnumed.120.259069
Katherine A. Zukotynski
1 University of Toronto;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urban Emmenegger
1 University of Toronto;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastien Hotte
2 McMaster University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Kapoor
2 McMaster University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Fu
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda L. Blackford
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Valliant
4 McMaster;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
5 British Columbia Cancer Agency;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chun K. Kim
6 Hanyang University College of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark C. Markowski
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario A. Eisenberger
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel S. Antonarakis
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth J. Pienta
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Gorin
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Lubanovic
2 McMaster University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jihyun Kim
7 University of Wisconsin;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin G. Pomper
8 Johns Hopkins Medical Institutions;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Y. Cho
9 University of Wisconsin School of Medicine and Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven P. Rowe
3 Johns Hopkins University School of Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.120.259069
DOI 
https://doi.org/10.2967/jnumed.120.259069
PubMed 
33608426

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online February 19, 2021.

Copyright & Usage 
Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Katherine A. Zukotynski1,
  2. Urban Emmenegger1,
  3. Sebastien Hotte2,
  4. Anil Kapoor2,
  5. Wei Fu3,
  6. Amanda L. Blackford3,
  7. John Valliant4,
  8. Francois Benard5,
  9. Chun K. Kim6,
  10. Mark C. Markowski3,
  11. Mario A. Eisenberger3,
  12. Emmanuel S. Antonarakis3,
  13. Kenneth J. Pienta3,
  14. Michael A. Gorin3,
  15. Matthew Lubanovic2,
  16. Jihyun Kim7,
  17. Martin G. Pomper8,
  18. Steve Y. Cho9 and
  19. Steven P. Rowe3
  1. 1 University of Toronto;
  2. 2 McMaster University;
  3. 3 Johns Hopkins University School of Medicine, United States;
  4. 4 McMaster;
  5. 5 British Columbia Cancer Agency;
  6. 6 Hanyang University College of Medicine;
  7. 7 University of Wisconsin;
  8. 8 Johns Hopkins Medical Institutions;
  9. 9 University of Wisconsin School of Medicine and Public Health
  1. For correspondence or reprints contact: Steven P. Rowe, Johns Hopkins University School of Medicine, 601 N. Caroline St. JHOC Room 3233, Baltimore, MD 21287, United States. E-mail: srowe8@jhmi.edu

Article usage

Article usage: to

AbstractFullPdf
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (3)
Journal of Nuclear Medicine
Vol. 62, Issue 3
March 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, Francois Benard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho, Steven P. Rowe
Journal of Nuclear Medicine Feb 2021, jnumed.120.259069; DOI: 10.2967/jnumed.120.259069

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, Francois Benard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho, Steven P. Rowe
Journal of Nuclear Medicine Feb 2021, jnumed.120.259069; DOI: 10.2967/jnumed.120.259069
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • 18F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with 18F-FDG PET/CT as reference standard
  • A Prospective Randomized, Double-blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-differentiated Neuroendocrine Tumors
Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

  • Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
  • Diagnostic Value, Oncological Outcomes And Safety Profile Of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy For Prostate Cancer.
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • molecular imaging
  • Oncology: GU
  • PET/CT
  • Anti-androgen
  • CRPC
  • prognosis
  • radiopharmaceutical
  • response assessment
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire